Alkermes (ALKS) Receivables - Other (2015 - 2025)
Alkermes' (ALKS) quarterly Receivables - Other came in at $65.8 million in Q4 2025, down 5.32% year-on-year from $69.5 million in Q4 2024, and up 9077.13% on a QoQ basis from $717000.0 in Q3 2025.
Alkermes (ALKS) Receivables - Other (2015 - 2025) Analysis & Trends
Alkermes (ALKS) has 10 years of Receivables - Other data on file, last reported at $65.8 million in Q4 2025.
- On a quarterly basis, Receivables - Other fell 5.32% year-over-year to $65.8 million in Q4 2025; TTM through Dec 2025 was $65.8 million, a 5.32% decrease from a year earlier, with the FY2025 full-year figure at $65.8 million, down 5.32% from the prior year.
- Receivables - Other for Q4 2025 stood at $65.8 million, up from $717000.0 in the prior quarter.
- Over the last five years, Receivables - Other for ALKS reached as high as $127.6 million in Q4 2021 and fell as low as $706000.0 in Q4 2023.
- Historically, Receivables - Other has averaged $22.5 million across 5 years, with a median of $8.4 million in 2023.
- Across the five-year window, Receivables - Other slumped 99.02% in 2023 and jumped 9744.19% in 2024, its largest moves.
- Year by year, Receivables - Other stood at $127.6 million in 2021, then tumbled by 43.57% to $72.0 million in 2022, then slumped by 99.02% to $706000.0 in 2023, then soared by 9744.19% to $69.5 million in 2024, then decreased by 5.32% to $65.8 million in 2025.
- Per Business Quant data, the three most recent Receivables - Other figures were $65.8 million in Q4 2025, $717000.0 in Q3 2025, and $1.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.80 Mn |
| Dec 31, 2025 | 65.80 Mn |
| Sep 30, 2025 | 717,000.00 |
| Sep 30, 2025 | 717,000.00 |
| Jun 30, 2025 | 1.42 Mn |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 69.50 Mn |
| Dec 31, 2024 | 69.50 Mn |
| Sep 30, 2024 | 2.97 Mn |
| Sep 30, 2024 | 2.97 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 706,000.00 |
| Dec 31, 2023 | 706,000.00 |
| Sep 30, 2023 | 2.77 Mn |
| Sep 30, 2023 | 2.77 Mn |